[1] Sun SC.The noncanonical NF-κB pathway[J].Immunol Rev,2012,246(1):125-140. [2] Sun SC.Non-canonical NF-κB signaling pathway[J].Cell Res,2011,21(1):71-85. [3] Karin M,Cao Y,Greten FR,et al.NF-kappaB in cancer:from innocent bystander to majorCulprit[J].Nat Rev Cancer,2002,2(4):301-310. [4] Lee SA,Kim HJ,Chang KC,et al.DHA and EPA down-regulate COX-2 expression through suppression of NF-κB activity in LPS-treated human umbilical vein endothelial cells[J]. Korean J Physi and Pharmac,2009,13(4):301-307. [5] Trebec-Reynolds DP,Voronov I,Heersche JN,et al.VEGF-A expression in osteoclasts is regulated by NF-kappaB induction of HIF-l alpha[J].J Cell Biochem,2010,110(2):343-351. [6] Chu SH,Lim JW,Kim DG,et al.Down-regulation of Bcl-2 ismediated by NF-kappaB activation in Helicobacter pylori-induced apoptosis of gastric epithelial cells[J].Scand J Gastroenterol, 2011,46(2):148-155. [7] 李春雷,陈钟.NF-κB和PTEN蛋白在肝细胞肝癌中的表达及其意义[J].南通大学学报(医学版),2013,33(4):291-295. [8] Yu HB,Zhang HF,Zhang X,et al.Resveratrol inhibits VEGF expression of human hepatocellular carcinoma cells through a NF-kappa B-mediated mechanism[J].Hepatogastroenterology, 2010,57(102/103):1241-1246. [9] 张宇红,窦科峰.核因子-κB、bcl-2在肝癌的表达及其相关性[J].第四军医大学学报,2004,25(10): 918-920. [10] Hsieh MJ,Lin CW,Yang SF,et al.Glabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase 9 through modulation of NF-κB and AP-1 activity in human liver cancer cells[J].British J Pha,2014,171(12):3037-3050. [11] Zaynagetdinov R,Stathopoulos GT,Sherrill TP,et al.Epithelial nuclear factor-kB signaling promotes lung carcinogenesis via recruitment of regulatory T lymphocytes[J].Oncogene,2012, 31(26):3164-3176. [12] Davies AM,Lara PN Jr,Mack PC,et al.Incorporating bortezomibinto the treatment of lung cancer[J].Clin Cancer Res,2007,13(15):4647s-4651s. [13] Yang L,Zhou Y,Li Y,et al.Mutations of p53 and KRAS activate NF-kappaB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells[J].Cancer Lett,2015,357(2):520-526. [14] Zhang L,Ruan J,Yan L,et al.Xanthatin induces cell cycle arrest at G2/M checkpoint and apoptosis via disrupting NF-κB pathway in A549 non-small-cell lung cancer cells[J]. Molecules,2012,17(4):3736-3750. [15] Lee H,Kim JS,Kim E.Fucoidan from seaweed Fucus vesiculosus inhibits migration and invasion of human lung cancer cell via PI3K-Akt-mTOR pathways[J].PLoS One,2012,7(11): e50624. [16] Zeng Q, Li S, Zhou Y, et al.Interleukin-32 contributes to invasion and metastasis of primary lung adenocarcinoma via NF-kappaB induced matrix metalloproteinases 2 and 9 expression[J]. Cytokine,2014,65(1):24-32. [17] Cheng X,Gu J,Zhang M,et al.Astragaloside IV inhibits migration and invasionin human lung cancer A549 cells via regulating PKC-α-ERK1/2-NF-κB pathway[J].Int Immunopharmacol, 2014,23(1):304-313. [18] Gao P,Gao YJ,Liang HL.Effect of NF-κB inhibitor PDTC on VEGF and endostatin expression of mice with Lewis lung cancer[J].Asian Pac J Trop Med,2015,8(3):220-224. [19] Kumar M,Allison DF,Baranova NN,et al.NF-κB regulates mesenchymal transition for the induction of non-small cell lung cancer initiating cells[J].PLoS One,2013,8(7):1-10. [20] Li J,Jia H,Xie L,et a1.Association of constitutive nuclear factor-κB activation with aggressive aspects and poor prognosis in cervical cancer[J].Int J Gynecol Cancer,2009, 19(8):1421-1426. [21] James MA,Lee JH,Klingelhutz AJ.Human papillomavirus type 16 E6 activates NF-κB,induces cIAP-2 expression,and protects against apoptosis in a PDZ binding motif-dependent manner[J]. J Virol,2006,80(11):5301-5307. [22] Chen HW,Liu SS,Miao LF,et al.Inhibitory effect of lanthanum chloride on migration and invasion of cervical cancer cells[J].J Rare Earths,2013,31(1):94-100. [23] Sahin K,Tuzcu M,Basak N,et al.Sensitization of cervical cancer cells to cisplatin by genistein:the role of NF-κB and Akt/mTOR signaling pathways[J].J Oncol,2012,2012(3): 461562. [24] 邢丽娜,刘晓.NF-κB抑制对宫颈癌HeLa细胞放疗敏感性影响的观察[J].中华肿瘤防治杂志,2008,15(21):1636-1638. [25] Sasaki N,Morisaki T,HashiZume K,et aI.NucIear factor-kappaB p65(ReIA) transcription factor is constitutiveIy activated in human gastric carcinoma tissue[J].CIin Cancer Res, 2001,7(12):4136-4142. [26] 修丽娟,孙大志,刘宁宁,等.幽门螺杆菌阳性胃癌组织中RUNX3、NF-κB p65蛋白表达及临床意义[J].中华临床医师杂志(电子版),2016,10(1):11-15. [27] 李勇,耿建磊,檀碧波,等.胃癌组织核转录因子κB p65蛋白表达与肿瘤多药耐药性的关系[J].中国全科医学,2016,19(2):238-241. [28] Bailey ST,Miron PL,Choi YJ,et al.NF-kappaB activation-induced anti-apoptosis renders HER2-positive cells drug resistant and accelerates tumor growth[J].Mol Cancer Res,2014, 12(3):408-420. [29] Duru N,Candas D,Jiang G,et al.Breast cancer adaptive resistance: HER2 and cancer stem repopulation in a heterogeneous tumor society[J].Cancer Res Clin Oncol,2014,140(1):l-14. [30] Shibata A,Nagaya T,Imai T,et al.Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells[J].Breast Cancer Res and Treat,2002,73(3): 237-243. [31] Chen YJ,Yeh MH,Yu MC,et al.Lapatinib-induced NF-kappaB activation sensitizes triple- negative breast cancer cells to proteasome inhibitors[J].Breast Cancer Res,2013, 15(6):R108. [32] 濮勇,陈锁成.核转录因子-κB在结肠癌中的表达及临床意义[J].江苏大学学报(医学版),2012,22(4):350-353. [33] Babykutty S,S PP,J NR,et al.Nimbolide retards tumor cell migration,invasion,and angiogenesis by downregulating MMP-2/9 expression via Inhibiting ERK1/2 and reducing DNA-binding activity of NF-κB in colon cancer cells[J].Mol Carcinog,2012,51(6):475-490. [34] Suboj P,Babykutty S,Valiyaparambil Gopi DR,et al.Aloe emodin inhibits colon cancer cell migration/angiogenesis by downregulating MMP-2/9,RhoB and VEGF via reduced DNA binding activity of NF-κB[J].Euro J Pha Sci,2012,45(5):581-591. [35] Guo RX,Qiao YH,Zhou Y,et al.Increased staining for phosphorylated AKT and nuclear factor-κB p65 and their relationship with prognosis in epithelial ovarian cancer[J].Pathol Int,2008,58(12):749-756. [36] Mahindra A,Laubach J,Raje N,et al.Latest advances and current challenges inthe treatment of multiple myeloma[J].Nat Rev Clin Oncol,2012,9(3):135-143. [37] Hoesel B,Schmid JA.The complexity of NF-κB signaling in inflammation and cancer[J].Mol Cancer,2013,12(1):1-15. [38] Li X,Abdel-Mageed AB,Mondal D,et a1.The nuclear factor kappa-B signaling pathway as a therapeutic target against thyroid cancers[J].Thyroid,2013,23(2):209-218. [39] Ding XZ,Tong WG,Adrian TE.Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells[J].Anticancer Res,2000,20(4):2625-2631. |